Reversible hyperinsulinuria in diabetic ketoacidosis in man.
Urinary clearance and fractional urinary clearance of immunoreactive insulin (IRI) and beta 2-microglobulin (I beta 2M) were studied in patients with diabetic ketoacidosis (DKA) before, during, and after treatment. Our results indicate that in DKA in man a) there is an approximate 250-fold increase in urinary and fractional urinary clearance of IRI and a 600-fold increase in urinary and fractional urinary I beta 2M clearance, which suggests that the hyperinsulinuria is secondary to a nonspecific defect in tubular luminal uptake of low-molecular-weight proteins, although decreased IRI degradation cannot be excluded; b) because increased IRI clearance is not changed by the pharmacologic plasma IRI levels achieved, the residual tubular absorptive capacity is not saturable; c) I beta 2M clearance but not IRI clearance is significantly improved by the time metabolic control is attained, suggesting separate tubular transport systems; d) a small, therapeutically insignificant fraction of the infused insulin is lost in the urine during therapy of DKA; and e) defective renal tubular luminal uptake (and possibly degradation) of IRI is reversible.
D000293:Adolescent; D000328:Adult; D016883:Diabetic Ketoacidosis / Q000188:drug therapy / Q000652:urine*; D005260:Female; D006029:Glycosuria; D006801:Humans; D007328:Insulin / Q000097:blood / Q000627:therapeutic use / Q000652:urine*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D001613:beta 2-Microglobulin / Q000652:urine
D007328:Insulin; D001613:beta 2-Microglobulin